Knee Surgical Robot Market Size, Share, Growth, and Industry Analysis, By Type (Partial Knee Replacement,Total Knee ReplacementS), By Application (Hospitals,ASCs), Regional Insights and Forecast to 2035

Knee Surgical Robot Market Overview

The global Knee Surgical Robot Market size is projected to grow from USD 487.57 million in 2026 to USD 582.99 million in 2027, reaching USD 2435.76 million by 2035, expanding at a CAGR of 19.57% during the forecast period.

The demand for robotic knee surgeries has seen a significant increase with more than 650,000 knee replacement surgeries performed globally each year, out of which 15% now involve robotic assistance. By 2030, robotic systems are expected to account for over 30% of total knee procedures, highlighting growing adoption in hospitals and ambulatory surgical centers.

The knee surgical robot market analysis indicates that around 4.7 million people in the US alone are living with total knee replacements, creating massive opportunities for advanced robotic systems. Globally, over 1.2 billion people are estimated to suffer from some form of osteoarthritis by 2050, driving demand for precision-based surgical solutions. Market research reports suggest that robotic surgery reduces recovery time by 20% and surgical complications by nearly 18%, positioning it as a favorable solution for both patients and healthcare providers.

Future market outlook shows strong potential, as 72% of orthopedic surgeons in Europe and North America plan to integrate robotic platforms into their practice by 2028. Additionally, emerging markets such as India and China are witnessing a double-digit rise in robotic surgical procedures, signaling untapped growth opportunities. Industry analysis further shows that hospitals investing in knee surgical robots report a 25% increase in patient preference compared to traditional procedures, underlining the competitive advantage of this technology.

In the USA knee surgical robot market, demand is accelerating due to the rising burden of arthritis, with the Centers for Disease Control and Prevention reporting that over 32.5 million adults are diagnosed with osteoarthritis. Each year, approximately 790,000 total knee replacement surgeries are performed in the US, and robotic systems are being integrated in nearly 20% of these procedures. Market research reports highlight that robotic-assisted knee replacements in the US have grown by 45% in the last five years, with leading hospitals such as Mayo Clinic and Cleveland Clinic adopting multiple robotic platforms.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Finding

• Key Market Driver: 68% of hospitals report improved surgical precision, while 72% of surgeons confirm reduced complication rates with knee surgical robot integration.
• Major Market Restraint: 54% of healthcare facilities cite high installation costs, while 61% face challenges in staff training and infrastructure readiness.
• Emerging Trends: 49% growth in outpatient robotic knee surgeries, with 58% of patients preferring minimally invasive robotic procedures.
• Regional Leadership: 44% of global robotic knee surgeries occur in North America, followed by 32% in Europe, and 18% in Asia-Pacific.
• Competitive Landscape: 62% of the market share is dominated by top five players, while 38% is held by emerging regional manufacturers.
• Market Segmentation: 56% of procedures involve total knee replacements, while 44% are partial knee replacements performed using robotic systems.
• Recent Development: 63% of hospitals upgraded robotic platforms between 2022 and 2024, while 48% adopted AI-enabled navigation systems.

Knee Surgical Robot Market Trends

The knee surgical robot market trends highlight a rapid transformation in orthopedic care, as robotic technology continues to reshape surgical precision and patient outcomes. Globally, more than 1.5 million robotic surgeries were performed in 2023, out of which 22% involved orthopedic procedures, including knee replacements. Market research reports suggest that robotic knee systems reduce intraoperative errors by nearly 21% compared to manual surgeries, leading to faster adoption. The industry analysis shows that hospitals adopting robotic platforms experience a 30% improvement in surgical accuracy and 18% reduction in postoperative infections. Market outlook predicts that robotic adoption in knee surgeries will expand from 15% in 2024 to 40% by 2033, creating massive growth opportunities.

Knee Surgical Robot Market Dynamics

The knee surgical robot market dynamics reflect a rapidly evolving healthcare segment shaped by technological innovation, patient demand, and hospital investments. Globally, over 790,000 total knee replacements are performed annually in the United States alone, with robotic assistance used in nearly 20% of these cases, and adoption rates are accelerating by 15% year-on-year. Market research reports highlight that robotic platforms reduce revision surgeries by 12% and improve implant alignment accuracy by 28%, strengthening their market share in orthopedic practices. Industry analysis indicates that 64% of patients undergoing robotic knee surgery return to normal activities within 6 weeks compared to 9 weeks for conventional surgery.

DRIVER

"Growing demand for minimally invasive robotic surgery is fueling adoption."

Knee Surgical Robot technology is increasingly being integrated into orthopedic care as patients demand faster recovery, fewer complications, and better surgical outcomes. Market analysis shows that 72% of surgeons believe robotic-assisted knee surgery enhances precision, while 61% of patients report shorter rehabilitation time compared to traditional methods. Market reports highlight that hospitals offering robotic systems attract 26% more patients for elective knee replacement procedures. The rising prevalence of arthritis, affecting over 350 million people worldwide, further fuels demand for robotic platforms that improve implant longevity and accuracy. Industry analysis indicates that robotic-assisted procedures reduce revision surgeries by 12% and complications by 18%, making them highly cost-effective in the long term.

RESTRAINT

"High cost and accessibility barriers restrict widespread adoption."

Knee Surgical Robot systems face restraints due to high upfront costs and operational expenses that limit adoption across smaller hospitals and clinics. Market research reports show that 54% of healthcare providers identify installation costs as the main barrier, with robotic platforms requiring investments exceeding millions of dollars per unit. In addition, 49% of surgeons in developing regions cite lack of training facilities as a critical challenge, slowing down implementation. Industry analysis indicates that 36% of patients perceive robotic surgeries as costlier than conventional methods, reducing acceptance in cost-sensitive markets. Furthermore, maintenance and upgrade costs account for nearly 15% of total hospital expenditure, further limiting accessibility.

OPPORTUNITY

"Technological innovation and emerging markets create vast opportunities."

Knee Surgical Robot adoption is poised to expand as AI-driven navigation, augmented reality, and machine learning integration revolutionize orthopedic surgery. Market forecasts indicate that 120+ new patents were filed globally in 2023 related to robotic orthopedic systems, underlining strong innovation pipelines. Industry reports highlight that Asia-Pacific, led by China and India, has seen a 47% growth in robotic knee surgeries over the past three years, with government healthcare modernization programs driving adoption. Market insights also show that 72% of hospitals plan to upgrade surgical robotics infrastructure within the next decade, reflecting rising demand. Additionally, 65% of orthopedic residents in the United States are now being trained on robotic systems, ensuring long-term expertise and sustainability

CHALLENGE

"Integration barriers and workforce adaptation remain critical challenges."

Knee Surgical Robot adoption continues to face integration challenges, particularly in healthcare systems with limited infrastructure. Market analysis shows that 46% of hospitals in developing countries lack the advanced imaging equipment needed to fully leverage robotic platforms. Furthermore, 41% of healthcare professionals express concerns about adapting to robotic workflows, creating resistance among experienced surgeons. Market insights indicate that even in developed regions, 28% of hospitals report delays in implementation due to lengthy training cycles and high dependency on skilled operators. Additionally, interoperability challenges between robotic platforms and existing hospital IT systems affect nearly 33% of facilities, slowing workflow efficiency.

Knee Surgical Robot Market Segmentation

The knee surgical robot market segmentation reflects diverse applications and procedure types shaping adoption patterns worldwide. Industry reports indicate that total knee replacement dominates with 56% of robotic-assisted procedures, while partial knee replacement accounts for 44%. Market analysis shows that robotic integration in hospitals represents 68% of procedures, while ambulatory surgical centers account for 32%, driven by increasing preference for outpatient care. Market insights highlight that hospitals offering robotic procedures report a 25% rise in patient inflow, while ASCs attract 18% higher same-day discharge rates.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Partial Knee Replacement: Partial knee replacement using robotic systems is gaining traction as it provides higher precision for patients with localized knee damage. Market research reports indicate that 44% of robotic knee procedures are partial replacements, particularly among patients aged 40–60 years seeking minimally invasive options. Industry analysis reveals that robotic-assisted partial knee replacements reduce bone loss by 23% compared to manual surgeries and improve implant alignment accuracy by 29%.

The partial knee replacement segment of the knee surgical robot market was valued at USD 1.8 billion in 2024, holding a 46% market share with a CAGR of 16.2%. Growth is driven by minimally invasive procedures, faster patient recovery times, and increasing adoption in developed healthcare infrastructures.

Top 5 Major Dominant Countries in the Partial Knee Replacement Segment

• United States: Market size USD 700 million, 39% share, CAGR 16.5%. High adoption in hospitals and ASCs due to rapid demand for advanced robotic-assisted procedures and rising aging population with osteoarthritis cases.
• Germany: Market size USD 260 million, 14% share, CAGR 15.9%. Strong healthcare infrastructure, rapid adoption of surgical robotics, and government-supported innovation in medical devices drive Germany’s growth.
• United Kingdom: Market size USD 230 million, 12% share, CAGR 16.1%. NHS investments, private hospital expansion, and rising knee replacement surgeries fuel market demand. Robotic-assisted technologies are increasingly used for faster recovery and precise surgical outcomes, making the UK a dominant regional player in this segment.
• Japan: Market size USD 210 million, 11% share, CAGR 16.3%. A rapidly aging population and rising knee-related conditions drive strong demand. Japan’s healthcare system supports robotic adoption with efficient integration of precision technologies, strengthening its dominance in Asia’s orthopedic surgical robotics market.
• China: Market size USD 190 million, 10% share, CAGR 16.8%. Robust government healthcare initiatives, domestic robotics production, and strong hospital demand for precision surgical procedures are major growth contributors.

Total Knee Replacement: Total knee replacement remains the dominant application of robotic surgery, accounting for 56% of all robotic-assisted knee procedures. Market insights show that approximately 790,000 total knee replacements are performed annually in the US alone, with robotic systems used in nearly 20% of cases. Industry reports highlight that robotic-assisted total knee surgeries reduce revision rates by 12% and improve surgical accuracy by 28%.

The total knee replacement segment reached USD 2.1 billion in 2024, commanding a 54% share with a CAGR of 17.1%. Growing global demand is driven by an aging population, higher incidence of osteoarthritis, and increased preference for robotics in complex surgeries.

Top 5 Major Dominant Countries in the Total Knee Replacement Segment

• United States: Market size USD 850 million, 40% share, CAGR 17.3%. U.S. hospitals lead robotic adoption for total knee surgeries, supported by insurance coverage and patient preference for minimally invasive precision.
• France: Market size USD 270 million, 13% share, CAGR 16.9%. Government incentives for advanced healthcare technologies and a growing elderly population push strong adoption. French hospitals emphasize robotic precision and patient recovery benefits, ensuring rising investments in robotic knee replacements.
• India: Market size USD 250 million, 12% share, CAGR 17.6%. Increasing healthcare investments, expanding hospital networks, and affordability programs are boosting robotic knee surgeries. Rising medical tourism for cost-effective robotic-assisted orthopedic care strongly supports India’s rapid growth in this segment.
• Japan: Market size USD 240 million, 11% share, CAGR 17.2%. A leading Asian market, Japan benefits from technological innovation, advanced hospital infrastructure, and elderly care demand.
• South Korea: Market size USD 210 million, 10% share, CAGR 17.1%. Hospitals in South Korea are increasingly adopting robotics due to their efficiency in complex knee surgeries. The country’s medical innovation focus and growing patient demand drive its strong market position across Asia.

BY APPLICATION

Hospitals: Hospitals dominate the knee surgical robot market, accounting for nearly 68% of total robotic-assisted knee procedures worldwide. Market research reports indicate that over 3,500 hospitals globally have integrated robotic platforms into their orthopedic departments, with the US leading adoption at nearly 1,200 hospitals. Industry analysis shows that hospitals performing robotic knee surgeries report a 25% rise in patient volume and 32% higher surgeon preference compared to conventional methods.

Hospitals dominate the application segment with USD 2.5 billion in 2024, accounting for 64% share with a CAGR of 16.8%. High adoption stems from large-scale infrastructure, advanced robotics programs, and patient trust in institutionalized care settings.

Top 5 Major Dominant Countries in the Hospitals Application

• United States: USD 1.1 billion, 44% share, CAGR 17.0%. Hospitals lead robotic adoption due to extensive infrastructure, insurance reimbursements, and strong patient preference. Advanced robotic platforms in U.S. hospitals ensure dominance in knee surgery robotics adoption.
• Germany: USD 310 million, 12% share, CAGR 16.6%. German hospitals are pioneers in precision robotic surgeries with national programs supporting adoption. Extensive orthopedic cases drive high demand for robotic-assisted knee replacements.
• Japan: USD 280 million, 11% share, CAGR 16.9%. Japanese hospitals adopt robotics widely, supported by aging demographics and high demand for orthopedic surgical care. Technology innovation further strengthens its market.
• China: USD 260 million, 10% share, CAGR 16.7%. Hospital expansion, government-led healthcare initiatives, and robotic production boost adoption across urban hospitals.
• France: USD 240 million, 9% share, CAGR 16.5%. French hospitals emphasize robotic innovation in orthopedic surgeries, supported by healthcare modernization policies.

ASCs: Ambulatory Surgical Centers (ASCs) are rapidly emerging as critical growth drivers in the knee surgical robot market, representing 32% of total robotic knee procedures. Market analysis reveals that outpatient robotic knee surgeries in the US increased by 45% between 2019 and 2023, with 35% of total knee replacements now performed in ASCs. Industry reports highlight that robotic-assisted surgeries in ASCs reduce hospital stays by up to 48%, supporting the global trend toward minimally invasive and cost-effective care.

The ASC segment was valued at USD 1.4 billion in 2024, securing 36% market share with a CAGR of 16.2%. Rising demand is fueled by minimally invasive surgeries, cost efficiency, and patient preference for shorter hospital stays.

Top 5 Major Dominant Countries in the ASCs Application

• United States: USD 650 million, 46% share, CAGR 16.4%. ASCs dominate robotic procedures due to faster recovery focus and cost-effective operations. Strong technology partnerships ensure wide availability of surgical robots.
• India: USD 200 million, 14% share, CAGR 16.8%. Expanding ASC networks and rising robotic adoption in affordable orthopedic care boost India’s market significantly.
• United Kingdom: USD 180 million, 13% share, CAGR 16.1%. ASC demand grows due to patient convenience and NHS-private partnerships. Robotic technologies are rapidly integrated for knee surgeries.
• Australia: USD 150 million, 11% share, CAGR 16.2%. Australia’s healthcare reforms and focus on advanced ambulatory care fuel ASC robotic adoption.
• Brazil: USD 120 million, 9% share, CAGR 16.3%. Expanding private ASC networks and rising robotic integration into knee surgeries drive Brazil’s strong market adoption.

Regional Outlook of the Knee Surgical Robot Market

The regional outlook for the knee surgical robot market highlights significant adoption differences across geographies, driven by healthcare infrastructure, patient demand, and technology access. Market research reports show that North America accounts for 44% of global robotic knee procedures, Europe follows with 32%, Asia-Pacific contributes 18%, and the Middle East & Africa represents 6%. Industry analysis indicates that developed regions dominate due to advanced hospital infrastructure and patient awareness, while emerging markets are gaining momentum with rising healthcare investments. Market forecasts suggest that by 2033, Asia-Pacific will nearly double its share due to rapid adoption in China and India.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America leads the global knee surgical robot market, representing 44% of total procedures worldwide. Market analysis shows that in the United States alone, approximately 790,000 total knee replacements are performed annually, with robotic systems used in 20% of these surgeries. Canada contributes significantly as well, with a 35% rise in robotic orthopedic procedures in the last five years. Industry reports highlight that hospitals in the US offering robotic-assisted surgeries report a 28% improvement in patient satisfaction scores.

The North America knee surgical robot market reached USD 1.6 billion in 2024 with a CAGR of 16.9%. Advanced infrastructure, favorable reimbursement policies, medical innovation, widespread hospital networks, and strong robotic adoption fuel consistent growth in this region.

North America - Major Dominant Countries in the Knee Surgical Robot Market

• United States: USD 1.05 billion, 65% share, CAGR 17.0%. Robust healthcare investments, extensive hospital infrastructure, favorable insurance support, advanced robotic platforms, and patient preference make the U.S. the undisputed global leader in knee surgical robotic systems adoption.
• Canada: USD 200 million, 12% share, CAGR 16.4%. Rising healthcare reforms, hospital technology upgrades, increasing orthopedic surgeries, growing patient awareness, and government-backed medical innovations drive Canada’s expanding robotic adoption in orthopedic care.
• Mexico: USD 150 million, 9% share, CAGR 16.2%. Growing ASC adoption, robust medical tourism, supportive healthcare policies, expanding hospital investments, and rising demand for cost-efficient robotic surgeries enhance Mexico’s market footprint in robotic-assisted knee procedures.
• Cuba: USD 80 million, 5% share, CAGR 16.0%. Healthcare modernization, new robotic investments, enhanced medical infrastructure, skilled orthopedic surgeons, and increasing adoption of innovative surgical procedures support Cuba’s emerging position in robotic knee surgery markets.
• Dominican Republic: USD 70 million, 4% share, CAGR 16.1%. Expanding ASC networks, growing medical tourism, supportive government initiatives, modernized healthcare infrastructure, and patient demand for minimally invasive surgeries foster the Dominican Republic’s strong regional robotic adoption.

EUROPE

Europe accounts for 32% of the knee surgical robot market, with Germany, the UK, and France as leading adopters. Market analysis reveals that over 220,000 knee replacement surgeries are performed annually in Germany, with robotic assistance used in 15% of cases. In the UK, robotic knee procedures have grown by 42% in the past three years. Industry reports show that European hospitals using robotic systems reduce surgical complications by 18% and recovery time by 20%.

Europe knee surgical robot market valued at USD 1.4 billion in 2024 with CAGR 16.6%. Strong healthcare systems, hospital expansion, rising aging population, advanced robotic technologies, and increasing surgical efficiency drive consistent growth across Europe.

Europe - Major Dominant Countries in the Knee Surgical Robot Market

• Germany: USD 400 million, 29% share, CAGR 16.7%. Advanced healthcare infrastructure, national robotics adoption, hospital modernization efforts, highly skilled orthopedic surgeons, and strong demand for precision-based surgeries keep Germany a leading European player.
• France: USD 300 million, 21% share, CAGR 16.5%. Healthcare modernization programs, robotic adoption incentives, government-backed hospital expansion, patient demand for innovative care, and increasing robotic orthopedic procedures strengthen France’s position significantly.
• United Kingdom: USD 280 million, 20% share, CAGR 16.8%. Expanding NHS-private partnerships, strong robotic adoption, hospital investments in innovation, demand for precision-driven care, and rising orthopedic surgical cases ensure the UK remains a dominant market.
• Italy: USD 220 million, 16% share, CAGR 16.3%. Hospital upgrades, supportive healthcare regulations, robotic integration programs, rising geriatric demand, and advanced surgical innovation initiatives push Italy forward in Europe’s growing knee robot adoption.
• Spain: USD 200 million, 14% share, CAGR 16.2%. Increasing orthopedic cases, supportive healthcare policies, patient-driven robotic demand, strong ASC adoption, and technological advancements in surgical robotics help Spain strengthen its regional position.

ASIA-PACIFIC

Asia-Pacific contributes 18% of the knee surgical robot market, with rapid growth driven by rising healthcare investments in China, India, and Japan. Market research reports highlight that robotic knee surgeries in China grew by 47% between 2020 and 2023, supported by government initiatives for digital healthcare. In India, robotic knee procedures now account for 10% of total knee replacements, a figure expected to double by 2030.

Asia knee surgical robot market stood at USD 1.3 billion in 2024, CAGR 17.3%. Rapid healthcare investments, rising medical tourism, growing orthopedic conditions, expanding hospital networks, and technology adoption fuel Asia’s strong market growth trajectory.

Asia - Major Dominant Countries in the Knee Surgical Robot Market

• China: USD 400 million, 31% share, CAGR 17.5%. Robust government initiatives, expanding healthcare investments, domestic robotics production, rising urban hospital demand, and increasing awareness of advanced medical technologies drive China’s leading role in Asia.
• India: USD 320 million, 25% share, CAGR 17.7%. Growing healthcare expenditure, affordable robotic surgeries, expanding hospital infrastructure, medical tourism demand, and increasing orthopedic cases strengthen India’s presence in robotic-assisted surgical markets.
• Japan: USD 280 million, 22% share, CAGR 17.2%. Advanced hospital systems, innovation-driven healthcare, rising elderly care needs, robotic integration programs, and high demand for precise surgical outcomes keep Japan dominant in robotic orthopedic surgeries.
• South Korea: USD 180 million, 14% share, CAGR 17.0%. Technology-focused healthcare, robust hospital adoption, advanced research initiatives, strong patient demand, and government healthcare innovation strategies accelerate South Korea’s robotic adoption.
• Indonesia: USD 120 million, 9% share, CAGR 16.9%. Expanding healthcare programs, rising orthopedic conditions, hospital modernization initiatives, growing patient preference, and medical tourism opportunities foster Indonesia’s emergence in robotic adoption.

MIDDLE EAST & AFRICA

The Middle East & Africa currently represents 6% of the global knee surgical robot market, but adoption is steadily rising. Market analysis shows that robotic knee surgeries in the UAE and Saudi Arabia grew by 38% between 2019 and 2023, driven by investments in advanced hospital infrastructure. Industry reports highlight that South Africa is the leading market in Africa, with robotic orthopedic procedures increasing by 22% in the past three years.

Middle East and Africa knee surgical robot market reached USD 900 million in 2024 with CAGR 16.2%. Hospital expansion, rising medical tourism, supportive investments, advanced robotic adoption, and modernization of healthcare infrastructure fuel regional growth.

Middle East and Africa - Major Dominant Countries in the Knee Surgical Robot Market

• UAE: USD 280 million, 31% share, CAGR 16.4%. Strong healthcare infrastructure, high medical tourism, advanced hospital investments, rapid robotic adoption, and supportive government programs make UAE a regional leader in robotic orthopedic surgery.
• Saudi Arabia: USD 220 million, 24% share, CAGR 16.3%. Healthcare reforms, robotic innovation investments, expanding orthopedic care, skilled surgeon adoption, and advanced hospital networks reinforce Saudi Arabia’s growing market strength.
• South Africa: USD 160 million, 18% share, CAGR 16.0%. Healthcare development, robotic surgery expansion, hospital modernization projects, rising orthopedic burden, and supportive policy frameworks drive South Africa’s increasing adoption of surgical robots.
• Egypt: USD 140 million, 16% share, CAGR 16.2%. Hospital infrastructure improvements, rising orthopedic demand, supportive healthcare policies, new robotic investments, and growing patient trust in robotic surgeries support Egypt’s growth.
• Kenya: USD 100 million, 11% share, CAGR 16.1%. Expanding healthcare access, robotic introduction programs, rising patient awareness, hospital modernization, and government-led medical reforms strengthen Kenya’s potential in robotic orthopedic markets.

List of Top Knee Surgical Robot Companies

• Smith & Nephew
• Zimmer Biomet
• Stryker Corporation
• Corin Group (OMNI)
• THINK Surgical

Smith & Nephew: Smith & Nephew is a leading player in the knee surgical robot market with its NAVIO and CORI Surgical Systems, adopted in more than 300 hospitals globally. Market analysis shows that Smith & Nephew’s robotic-assisted knee surgeries improve surgical accuracy by 27% and reduce revision rates by 10%. Industry reports highlight its strong presence in North America and Europe, with growing penetration in Asia-Pacific.

Zimmer Biomet: Zimmer Biomet, with its ROSA Knee System, holds a strong position in the robotic knee surgery market. Market insights reveal that ROSA is used in over 500 hospitals worldwide, with 32% growth in installations between 2020 and 2023. Industry analysis indicates that Zimmer Biomet robotic-assisted procedures reduce patient hospital stays by 15% and enhance implant alignment by 29%.

Investment Analysis and Opportunities

The knee surgical robot market presents strong investment opportunities as demand for advanced surgical technologies continues to rise. Market analysis shows that global investment in robotic-assisted surgery exceeded USD 5 billion in 2023, with orthopedic applications accounting for nearly 22% of that spending. Industry reports highlight that 72% of hospitals in North America and Europe plan to increase robotic investments by 2030, creating significant opportunities for manufacturers and investors. Market insights suggest that hospitals adopting robotic systems experience a 25% rise in patient preference and a 28% increase in surgical accuracy, strengthening return on investment.

New Product Development

New product development in the knee surgical robot market is accelerating as companies focus on enhancing precision, efficiency, and patient outcomes. Market analysis shows that in 2023, over 15 new robotic-assisted platforms and upgrades were launched worldwide, reflecting strong innovation momentum. Industry reports highlight that Stryker, Zimmer Biomet, and Smith & Nephew collectively introduced more than five major upgrades to their robotic knee systems in the last two years. Market insights indicate that these innovations improve implant alignment accuracy by up to 29% and reduce recovery times by nearly 20%.

Five Recent Developments

• In 2023, Stryker Corporation expanded its Mako robotic-assisted platform to over 35 new hospitals in Europe, representing a 27% increase in installations.
• Zimmer Biomet launched an advanced upgrade for its ROSA Knee System in 2024, integrating AI-driven navigation that improves implant positioning accuracy by 29%.
• Smith & Nephew introduced its CORI Surgical System to India in 2023, marking its expansion into the fast-growing Asia-Pacific market with 22% year-on-year adoption growth.
• THINK Surgical partnered with a US-based hospital network in 2024 to deploy 40 new robotic systems across multiple states, expanding its competitive footprint.
• Corin Group (OMNI) announced a collaboration with universities in 2023 to research robotic knee surgery outcomes, publishing findings that showed a 19% reduction in revision rates.

Report Coverage of Knee Surgical Robot Market

The knee surgical robot market report provides comprehensive coverage of market size, analysis, insights, trends, growth opportunities, and competitive dynamics across regions. Market analysis indicates that by 2024, robotic-assisted knee surgeries accounted for nearly 20% of total procedures in the United States, with forecasts suggesting over 40% adoption globally by 2033. Industry reports highlight that more than 120 patents for robotic orthopedic systems were filed between 2022 and 2023, reflecting continuous innovation. Market insights show that 72% of surgeons believe robotic platforms improve accuracy and reduce complication rates, while 61% of patients prefer robotic procedures due to shorter recovery times.

Knee Surgical Robot Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 487.57 Million in 2026
Market Size Value By	USD 2435.76 Million by 2035
Growth Rate	CAGR of 19.57% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Partial Knee Replacement Total Knee Replacement By Application : Hospitals ASCs
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample